Around The Web

“Pfizer has quietly recalled three lots of its blockbuster drug Lyrica because of a manufacturing problem that could have left some capsules deformed or...

Radio Boston remembers Marvin Minsky, MIT professor and founder of the artificial intelligence field. “Most importantly, Marvin Minsky changed the way think about the...

Only months after the American Psychological Association voted to ban psychologists from “advanced interrogation” facilities like Guantánamo Bay prison the Pentagon is asking them to...

Vox interviews twenty scientists about their biggest gripes with the journalists who report on their studies. For example, “journalists often want clear answers to...

Writing for Huffpost, medical doctor Lawrence Diller looks at the effects of the ever increasing diagnoses for ADHD and the addiction and abuse issues...

Emma Granqvist is leading the push for open access journals, like New Negatives in Plant Science, which are platforms for negative, unexpected or controversial results in...

Reuters reports that a new drug for major depression failed to improve symptoms in two late-stage clinical trials sending the manufacture’s stock into a...

A study out of the University of Buffalo explores the use of Narrative Exposure Therapy to treat youth PTSD and substance abuse. “Trauma is...

Plaintiffs allege that Bristol-Myers Squibb and Otsuka Pharmaceutical failed to warn doctors and patients about the risk for compulsive behaviors when taking the atypical...

Writing for the Harvard Health Blog, Dr. Nandinia Mani reconsiders the use of antidepressants in teens in light of the reanalysis of Study 329. ...

Saturday Night Live presents and advertisement for a drug that can “destroy the damaged part of the brain that says, ‘I’m going to be...

Medical News Today provides an overview of the research on the effects of shift work on the physical and mental well-being of employees. "Although...

Human Givens is a biannual journal that “explores the relevance of the very latest knowledge about human psychology and the way we live today.”...

“A quick look at drugs or drug uses that later turned out to be risky shows a disturbing trail of ‘bought’ science in major medical...

Writing for the Atlantic, Emma Yasinski confesses that she was enrolled in a clinical trial for an invasive experimental surgery at seven years old but, as the results were never published, she may never know how well it actually worked.

Barbara Ehrenreich has been a strident critic of positive psychology. Jason Marsh explores whether she might be missing something when it comes to the research on gratitude.

Just last week one person was declared brain dead and five more were hospitalized after taking a psychiatric drug in a clinical trial. Writing for Science, Martin Enserink provides more information about the drug as new details emerge.

The warning label for the antidepressant Cymbalta downplayed the risks of withdrawal effects, according to consumer lawsuits being filed in courts across the country. “An estimated 44% to 78% of people who stop taking Cymbalta (also known as duloxetine) will suffer from withdrawal reactions,” yet the warning label “suggests the risk is greater than or equal to 1%.”

“Children from poorer families are more likely to experience changes in brain connectivity that put them at higher risk of depression, compared with children from more affluent families,” according to new research covered by Medical News Today. "Poverty doesn't put a child on a predetermined trajectory, but it behooves us to remember that adverse experiences early in life are influencing the development and function of the brain. And if we hope to intervene, we need to do it early so that we can help shift children onto the best possible developmental trajectories."

A UK mother has won a three-year battle to have warning labels put on epilepsy drugs which cause birth defects, heart problems, and learning disabilities.

According to new research summarized by ScienceDaily, there is evidence that the brain prepares for multiple possible actions before a decision is made.

“Wealth in the United States can buy many things: education, homes, vacations. It can even buy the best doctors and diet, but it can't buy health.” Why not? Asks Yessenia Funes. Researchers find that inequality in society leads to shorter lives for everyone.

The Boston Globe reports on the discovery of a newly recognized neurological disease, anti-NMDA receptor encephalitis. The disease is believed to be caused when the body’s immune system attacks proteins in the brain associated with the communication of neurons.

PsychCentral covers new research linking social deprivation, population density and inequality with higher rates of psychotic symptoms and diagnoses for schizophrenia. “This is important because other research has shown that many health and social outcomes also tend to be optimal when societies are more equal.”

“No, cortisol in hair can’t ‘reveal future mental health risk’ in children.” HealthNewsReview gives a low rating to a recent story in the Guardian that reported that cortisol levels in children’s hair might be a useful mental health screening tool.